Syneos Health

About Us

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries.

To learn more about how we are shortening the distance from lab to life® visit

Schedule a Meeting

Team Members

Patrick Melvin

Patrick Melvin

VP, Clinical Development and Head of Novel and Emerging Therapies

Pete Robinson

Peter Robinson

VP, Strategic Alliances and Head of Cell and Gene Therapy Consortium

Ann Collins

Ann Collins

VP, Clinical Development, Novel and Emerging Therapies